ARCT Earnings

Quarterly EPS
$-0.26
Q3 2024
$-1.11
Q4 2024
$-0.52
Q1 2025
$-0.34
Q2 2025
$-0.49
Q3 2025
$-1.03
Q4 2025
$-0.95
Q1 2026
$-0.84
Q2 2026
Latest Revenue3.0M
Latest Net Income-23785000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.843.0M-23785000-89.5%-147.1%
Q1 2026-$0.952.1M-26964000-93.0%-82.7%
Q4 2025-$1.037.2M-29079000-68.4%+7.2%
Q3 2025-$0.4917.2M-13448000-58.8%-88.5%
Q2 2025-$0.3428.3M-9180000-43.2%+46.9%
Q1 2025-$0.5229.4M-14076000-22.7%+48.0%
Q4 2024-$1.1122.8M-30005000-26.2%-152.3%
Q3 2024-$0.2641.7M-6903000-7.7%+57.4%
Q2 2024-$0.6449.9M-17216000
Q1 2024-$1.0038.0M-26817000
Q4 2023-$0.4430.9M-11707000
Q3 2023-$0.6145.1M-16222000
Arcturus Therapeutics (ARCT) — Earnings